Tissuemed has begun a partnering initiative to offer other medical-device companies the chance to benefit from its adhesive polymer platform technology.
Tissuemed recently introduced the Tissuepatch range of multi-laminate absorbable surgical sealant films.
These are thin, synthetic, highly adherent films that act as a barrier to air, blood and other fluids encountered in surgery.
More adherent than surgical glues, the films are easy to apply, require no preparation and are effective within 30 seconds of contact.
The technology used in the Tissuepatch products has the potential to form the basis for new technologies or iterations of existing products.
Tissuemed's scheme, under the banner of Tissuemed Adhesive Biomaterials Technology Group, will take the form of a bespoke polymer design, synthesis and manufacturing programme open to suitable third parties, such as companies with medical devices that could be enhanced by the incorporation of adhesive characteristics, surfaces or components.
Examples of the types of surgical devices that may benefit from being self-adhesive to internal organs and structures include meshes, sutures, films and other implantable devices that may currently require physical means of anchoring.
The programme offers companies and surgeons the chance to work with Tissuemed's team of dedicated scientists to develop bespoke polymer designs and add new functionalities to their own products.
It also offers support in a range of other areas including clinical and regulatory, physical and biochemical testing, intellectual property protection and sales and marketing expertise.
